How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials
Expert Opin Emerg Drugs. 2023 Sep 26. doi: 10.1080/14728214.2023.2264182. Online ahead of print.NO ABSTRACTPMID:37750491 | DOI:10.1080/14728214.2023.2264182 (Source: Expert Opinion on Emerging Drugs)
Source: Expert Opinion on Emerging Drugs - September 26, 2023 Category: Drugs & Pharmacology Authors: Andrea Esposito Paolo Bossi Source Type: research
What's new on the horizon for polycystic ovarian syndrome? Exploring emerging drugs in phase II
Expert Opin Emerg Drugs. 2023 Sep 19:1-4. doi: 10.1080/14728214.2023.2260746. Online ahead of print.NO ABSTRACTPMID:37725478 | DOI:10.1080/14728214.2023.2260746 (Source: Expert Opinion on Emerging Drugs)
Source: Expert Opinion on Emerging Drugs - September 19, 2023 Category: Drugs & Pharmacology Authors: Giuseppe D'Angelo Mario Ascione Ilaria Morra Paolo Verrazzo Giuseppe Bifulco Pierluigi Giampaolino Luigi Della Corte Source Type: research
What's new on the horizon for polycystic ovarian syndrome? Exploring emerging drugs in phase II
Expert Opin Emerg Drugs. 2023 Sep 19. doi: 10.1080/14728214.2023.2260746. Online ahead of print.NO ABSTRACTPMID:37725478 | DOI:10.1080/14728214.2023.2260746 (Source: Expert Opinion on Emerging Drugs)
Source: Expert Opinion on Emerging Drugs - September 19, 2023 Category: Drugs & Pharmacology Authors: Giuseppe D'Angelo Mario Ascione Ilaria Morra Paolo Verrazzo Giuseppe Bifulco Pierluigi Giampaolino Luigi Della Corte Source Type: research
Emerging oral drug options for ulcerative colitis
This article aims to summarize the available evidence on oral drugs, which are now being explored in clinical trials or are ready to enter the clinics.AREAS COVERED: From May 15 to June 11, we searched on PubMed using the keywords 'oral drugs ulcerative colitis,' 'ulcerative colitis clinical trials,' 'UC phase 2 and 3 trials' excluding case reports, case series, phase 1 and 4 studies, and studies about approved therapies.EXPERT OPINION: The findings discussed in this article suggest that the future treatment of UC patients will be probably characterized by the possibility of using various small-molecule drugs. All these ne...
Source: Expert Opinion on Emerging Drugs - September 5, 2023 Category: Drugs & Pharmacology Authors: Silvia Salvatori Benedetto Neri Irene Marafini Mattia Brigida Giovanni Monteleone Source Type: research
